KRAS and pancreatic neoplasm: In Reg3B-deficient mice, Loncle et al.30 showed that PanIN lesions in the oncogenic Kras-driven PDAC model were attenuated and Gironella et al.33 showed that pancreatic tumor growth was impaired.